X
22Mar

HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers

Butler Snow LLP | | Return|
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By: Butler Snow LLP
Source Url: https://www.jdsupra.com/legalnews/hhs-declares-liability-immunity-for-40299/

Related

What CRAs Must Know: Important FAQs Regarding CFPB’s Recent Action for Employment Background Check Report Violations

Based on the public filing, the Bureau asserted that Sterling was engaged in the business of providi...

Read More >

NLRB Says Organizer Access To Public Spaces Is Not On The Menu

Over thirty-five years ago, the NLRB held that an employer may not prohibit a union organizer’s acc...

Read More >

Cannabis Legalization and Employee Drug Testing: A Tricky Combination

Drug testing has been a staple of the hiring process for decades, helping employers across industrie...

Read More >

DOJ and FTC Release New Vertical Merger Review Guidelines for Public Comment

On Friday, January 10, the Department of Justice’s Antitrust Division and the Federal Trade Commiss...

Read More >

SECURE Act Expands Retirement Savings, Increases Access To Plans

A new retirement savings law passed as part of the 2019 spending bill and signed by President Trump ...

Read More >

Transferring Personally Identifiable Information in Bankruptcy M&A - Part 2

With data privacy issues constantly in the news, what do businesses need to know about handling pers...

Read More >